Filing Details
REVELATION BIOSCIENCES, INC. (NASDAQ:REVB) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event.
8k filedNASDAQ:REVB
REVELATION BIOSCIENCES, INC. (REVB) Reports Material Event to SEC
Filing Details REVELATION BIOSCIENCES, INC. (NASDAQ:REVB) filed a Form 8-K with the Securities and Exchange Commission on June 24, 2026, disclosing a material event. Market…
Market Context
REVELATION BIOSCIENCES, INC.'s stock currently trades at $1.03 with a market capitalization of $6.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for REVELATION BIOSCIENCES, INC.'s stock.
All SEC filings for REVELATION BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View REVB Stock Page
Frequently Asked Questions
Where can I read REVB's SEC filings?
Browse all filings on our REVB SEC filings page.
What types of SEC filings does REVELATION BIOSCIENCES, INC. file?
Public companies like REVELATION BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.